STDs News

WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, said Wednesday that he will convene an emergency committee to determine if the increasing spread of mpox in Africa represents a public health emergency of international concern.

Testing HIV PrEP users for STIs every 6 months did not increase the risk for STIs compared with testing them every 3 months and could reduce the cost of PrEP programs, according to a study.

Post-exposure prophylaxis for HIV remained significantly underutilized, especially in acute care settings, according to study results published in Open Forum Infectious Diseases.

Rather than telling a patient they should get a vaccine, the CDC’s shared clinical decision-making recommendations advise patients to speak to providers about certain vaccines and decide on an individual basis if they should receive them. 

The following case, provided by Michael Cater, MD, a pediatrician at Children’s Hospital of Orange County, California, is the first of a two-part series.

Lenacapavir, an injectable antiretroviral drug approved by the FDA for HIV treatment, prevented 100% of new HIV infections among women in a phase 3 trial in Africa, demonstrating its efficacy as PrEP, Gilead Sciences said.

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

WHO reported a “major” increase in STIs in 2022, specifically highlighting an increase in syphilis and an insufficient decline in new HIV and viral hepatitis infections.

BOSTON — In this video, Healio Primary Care Peer Perspective Board Member Alan Dow, MD, MSHA, FACP, highlights important takeaways from the ACP Internal Medicine Meeting.